ArticleDrugs in R&D2026

A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors.

Javier Molina-Cerrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.